A detailed history of Private Trust CO Na transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Private Trust CO Na holds 136 shares of NBIX stock, worth $17,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136
Previous 45 202.22%
Holding current value
$17,088
Previous $6,000 150.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$114.58 - $153.15 $10,426 - $13,936
91 Added 202.22%
136 $15,000
Q1 2024

Apr 24, 2024

SELL
$130.4 - $143.74 $652 - $718
-5 Reduced 10.0%
45 $6,000
Q4 2023

Jan 24, 2024

BUY
$106.07 - $132.76 $5,303 - $6,638
50 New
50 $6,000
Q1 2023

Apr 12, 2023

SELL
$94.11 - $123.02 $188 - $246
-2 Reduced 2.78%
70 $7,000
Q4 2022

Jan 18, 2023

BUY
$106.72 - $127.06 $1,173 - $1,397
11 Added 18.03%
72 $0
Q3 2022

Oct 17, 2022

BUY
$92.03 - $107.81 $5,613 - $6,576
61 New
61 $6,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.